Search Results - "Kaspar, Brian"

Refine Results
  1. 1
  2. 2
  3. 3

    Glia–neuron interactions in neurological diseases: Testing non-cell autonomy in a dish by Meyer, Kathrin, Kaspar, Brian K

    Published in Brain research (01-02-2017)
    “…Abstract For the past century, research on neurological disorders has largely focused on the most prominently affected cell types – the neurons. However, with…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    A role for glia in the progression of Rett’s syndrome by Lioy, Daniel T., Garg, Saurabh K., Monaghan, Caitlin E., Raber, Jacob, Foust, Kevin D., Kaspar, Brian K., Hirrlinger, Petra G., Kirchhoff, Frank, Bissonnette, John M., Ballas, Nurit, Mandel, Gail

    Published in Nature (London) (28-07-2011)
    “…Astrocytes targeted in Rett's syndrome Rett's syndrome, a disorder caused by loss of function of methyl CpG-binding protein 2 (MeCP2), is associated with…”
    Get full text
    Journal Article
  10. 10

    Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes by Kaspar, Brian K, Foust, Kevin D, Nurre, Emily, Montgomery, Chrystal L, Hernandez, Anna, Chan, Curtis M

    Published in Nature biotechnology (01-01-2009)
    “…Foust et al . describe a viral vector that crosses the blood-brain barrier, providing a non-invasive method for delivering therapeutic genes to the central…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome by Garg, Saurabh K, Lioy, Daniel T, Cheval, Hélène, McGann, James C, Bissonnette, John M, Murtha, Matthew J, Foust, Kevin D, Kaspar, Brian K, Bird, Adrian, Mandel, Gail

    Published in The Journal of neuroscience (21-08-2013)
    “…De novo mutations in the X-linked gene encoding the transcription factor methyl-CpG binding protein 2 (MECP2) are the most frequent cause of the neurological…”
    Get full text
    Journal Article
  13. 13

    Therapeutic AAV9-mediated Suppression of Mutant SOD1 Slows Disease Progression and Extends Survival in Models of Inherited ALS by Foust, Kevin D, Salazar, Desirée L, Likhite, Shibi, Ferraiuolo, Laura, Ditsworth, Dara, Ilieva, Hristelina, Meyer, Kathrin, Schmelzer, Leah, Braun, Lyndsey, Cleveland, Don W, Kaspar, Brian K

    Published in Molecular therapy (01-12-2013)
    “…Mutations in superoxide dismutase 1 (SOD1) are linked to familial amyotrophic lateral sclerosis (ALS) resulting in progressive motor neuron death through one…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    NEUROD1 Instructs Neuronal Conversion in Non-Reactive Astrocytes by Brulet, Rebecca, Matsuda, Taito, Zhang, Ling, Miranda, Carlos, Giacca, Mauro, Kaspar, Brian K., Nakashima, Kinichi, Hsieh, Jenny

    Published in Stem cell reports (06-06-2017)
    “…Currently, all methods for converting non-neuronal cells into neurons involve injury to the brain; however, whether neuronal transdifferentiation can occur…”
    Get full text
    Journal Article
  17. 17

    Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates by Samaranch, Lluis, Salegio, Ernesto A, San Sebastian, Waldy, Kells, Adrian P, Foust, Kevin D, Bringas, John R, Lamarre, Clementine, Forsayeth, John, Kaspar, Brian K, Bankiewicz, Krystof S

    Published in Human gene therapy (01-04-2012)
    “…Widespread distribution of gene products at clinically relevant levels throughout the CNS has been challenging. Adeno-associated virus type 9 (AAV9) vector has…”
    Get more information
    Journal Article
  18. 18

    Transplantation of cerebellar neural stem cells improves motor coordination and neuropathology in Machado-Joseph disease mice by Mendonça, Liliana S, Nóbrega, Clévio, Hirai, Hirokazu, Kaspar, Brian K, Pereira de Almeida, Luís

    Published in Brain (London, England : 1878) (01-02-2015)
    “…Machado-Joseph disease is a neurodegenerative disease without effective treatment. Patients with Machado-Joseph disease exhibit significant motor impairments…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN by Kaspar, Brian K, Foust, Kevin D, Wang, Xueyong, McGovern, Vicki L, Braun, Lyndsey, Bevan, Adam K, Haidet, Amanda M, Le, Thanh T, Morales, Pablo R, Rich, Mark M, Burghes, Arthur H M

    Published in Nature biotechnology (01-03-2010)
    “…Spinal muscular atrophy (SMA), the most common autosomal recessive neurodegenerative disease affecting children, results in impaired motor neuron function…”
    Get full text
    Journal Article